Contemporary percutaneous coronary intervention versus balloon angioplasty for multivessel coronary artery disease - A comparison of the National Heart, Lung and Blood Institute Dynamic Registry and the Bypass Angioplasty Revascularization Investigation (BARI) study

被引:100
作者
Srinivas, VS
Brooks, MM
Detre, KM
King, SB
Jacobs, AK
Johnston, J
Williams, DO
机构
[1] Rhode Isl Hosp, Div Cardiol, Providence, RI 02903 USA
[2] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Med, Div Cardiovasc Med, Bronx, NY 10467 USA
[3] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA
[4] Fuqua Heart Ctr, Atlanta, GA USA
[5] Boston Univ, Med Ctr, Boston, MA USA
关键词
angioplasty; coronary disease; stents; registries; trials;
D O I
10.1161/01.CIR.0000031570.27023.79
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-This investigation compares the results of contemporary percutaneous coronary intervention (PCI) with standard balloon angioplasty among patients with multivessel coronary disease, Patients having balloon angioplasty in the Bypass Angioplasty Revascularization Investigation (BARI) and those within the Dynamic Registry meeting BARI eligibility criteria were studied, Methods and Results-Clinical features and in-hospital and 1-year outcomes of 857 BARI-eligible patients in the Dynamic Registry (contemporary PCI) were compared with the 904 randomized patients who underwent percutaneous transluminal coronary angioplasty in BARI. Compared with BARI patients, Registry patients had fewer lesions attempted (1.53 versus 2.56, P=0.001), more frequent single-vessel PCI (76% versus 33%, P<0.001), greater use of intracoronary stents (76% versus 1%, P<0.001), and GP IIb/IIIa receptor antagonist (24% versus 0%, P<0.001). Angiographic success was achieved more often among Registry patients (91% versus 72%, P<0.001), whereas abrupt closure (1.5% versus 9.5%, P<0.001) and in-hospital coronary artery bypass graft (CABG) (1.9% versus 10.2%, P<0.001) and myocardial infarction (0.8% versus 2.1%, P=0.025) were less common. No differences were observed in either in-hospital or 1-year death, but 1-year death/myocardial infarction was lower in the Registry, Registry patients had lower 1-year rates of subsequent CABG (8.6% versus 22.7%, P<0.001) and PCI (12.4% versus 22.5%, P<0.001). By multivariate analysis, ontemporary PCI was independently associated with reduced risk for in-hospital CABG, 1-year CABG, and 1-year PCI. Conclusions-Among patients with multivessel disease, contemporary PCI resulted in safer and more durable revascularization. These results support the role of PCI for selected patients with multivessel coronary artery disease.
引用
收藏
页码:1627 / 1633
页数:7
相关论文
共 18 条
[1]  
Alderman EL, 1996, NEW ENGL J MED, V335, P217
[2]   Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting - The Clopidogrel Aspirin Stent International Cooperative Study (CLASSICS) [J].
Bertrand, ME ;
Rupprecht, HJ ;
Urban, P ;
Gershlick, AH .
CIRCULATION, 2000, 102 (06) :624-629
[3]  
Chaitman BR, 1997, CIRCULATION, V96, P2162
[4]   Coronary revascularization in diabetic patients - A comparison of the randomized and observational components of the Bypass Angioplasty Revascularization Investigation (BARI) [J].
Detre, KM ;
Guo, P ;
Holubkov, R ;
Califf, RM ;
Sopko, G ;
Bach, R ;
Brooks, MM ;
Bourassa, MG ;
Shemin, RJ ;
Rosen, AD ;
Krone, RJ ;
Frye, RL ;
Feit, F .
CIRCULATION, 1999, 99 (05) :633-640
[5]  
Ellis SG, 1999, CIRCULATION, V100, P799
[6]   Clinical imaging of the high-risk or vulnerable atherosclerotic plaque [J].
Fayad, ZA ;
Fuster, V .
CIRCULATION RESEARCH, 2001, 89 (04) :305-316
[7]   A RANDOMIZED COMPARISON OF CORONARY-STENT PLACEMENT AND BALLOON ANGIOPLASTY IN THE TREATMENT OF CORONARY-ARTERY DISEASE [J].
FISCHMAN, DL ;
LEON, MB ;
BAIM, DS ;
SCHATZ, RA ;
SAVAGE, MP ;
PENN, I ;
DETRE, K ;
VELTRI, L ;
RICCI, D ;
NOBUYOSHI, M ;
CLEMAN, M ;
HEUSER, R ;
ALMOND, D ;
TEIRSTEIN, PS ;
FISH, RD ;
COLOMBO, A ;
BRINKER, J ;
MOSES, J ;
SHAKNOVICH, A ;
HIRSHFELD, J ;
BAILEY, S ;
ELLIS, S ;
RAKE, R ;
GOLDBERG, S .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (08) :496-501
[8]   Platelet glycoprotein IIb/IIIa integrin blockade with eptifibatide in coronary stent intervention - The ESPRIT trial: A randomized controlled trial [J].
O'Shea, JC ;
Hafley, GE ;
Greenberg, S ;
Hasselblad, V ;
Lorenz, TJ ;
Kitt, MM ;
Strony, J ;
Tcheng, JE .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2468-2473
[9]   METAANALYSIS OF RANDOMIZED TRIALS COMPARING CORONARY ANGIOPLASTY WITH BYPASS-SURGERY [J].
POCOCK, SJ ;
HENDERSON, RA ;
RICKARDS, AF ;
HAMPTON, JR ;
KING, SB ;
HAMM, CW ;
PUEL, J ;
HUEB, W ;
GOY, JJ ;
RODRIGUEZ, A .
LANCET, 1995, 346 (8984) :1184-1189
[10]   Argentine randomized study: Coronary angioplasty with stenting versus coronary bypass surgery in patients with multiple-vessel disease (ERACI II): 30-day and one-year follow-up results [J].
Rodriguez, A ;
Bernardi, V ;
Navia, J ;
Baldi, J ;
Grinfeld, L ;
Martinez, J ;
Vogel, D ;
Grinfeld, R ;
Delacasa, A ;
Garrido, M ;
Oliveri, R ;
Mele, E ;
Palacios, I ;
O'Neill, W .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (01) :51-58